BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27521996)

  • 1. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
    Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
    Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
    Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
    J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer.
    Chang CC; Kao WY; Liu CY; Su HH; Kan YA; Lin PY; Ku WC; Chang KW; Yang RN; Huang CJ
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer.
    Ma S; Yang D; Liu Y; Wang Y; Lin T; Li Y; Yang S; Zhang W; Zhang R
    Aging (Albany NY); 2018 Aug; 10(8):2062-2078. PubMed ID: 30144787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Meijer GA; Fijneman RJ
    Cell Oncol (Dordr); 2012 Aug; 35(4):293-300. PubMed ID: 22711543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.
    Zhu JH; Hong DF; Song YM; Sun LF; Wang ZF; Wang JW
    Asian Pac J Cancer Prev; 2013; 14(2):1017-21. PubMed ID: 23621178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.
    Tai CJ; Su TC; Jiang MC; Chen HC; Shen SC; Lee WR; Liao CF; Chen YC; Lin SH; Li LT; Shen KH; Yeh CM; Yeh KT; Lee CH; Shih HY; Chang CC
    J Transl Med; 2013 Jan; 11():29. PubMed ID: 23369209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
    Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
    Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression.
    Jiang MC; Yeh CM; Tai CJ; Chen HC; Lin SH; Su TC; Shen SC; Lee WR; Liao CF; Li LT; Lee CH; Chen YC; Yeh KT; Chang CC
    Am J Surg; 2013 Sep; 206(3):418-27. PubMed ID: 23806821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C.
    Lorenzato A; Martino C; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Olivero M; Di Renzo MF
    FASEB J; 2012 Jun; 26(6):2446-56. PubMed ID: 22389439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
    Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
    J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
    Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
    Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence.
    Tan F; Zhu H; He X; Yu N; Zhang X; Xu H; Pei H
    Int J Mol Med; 2018 Aug; 42(2):935-945. PubMed ID: 29749460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    Ashktorab H; Rahi H; Nouraie M; Shokrani B; Lee E; Haydari T; Laiyemo AO; Siegel P; Brim H
    BMC Cancer; 2018 Nov; 18(1):1068. PubMed ID: 30400781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_cse1l Inhibits Colorectal Cancer Proliferation by Binding to eIF4A3.
    Xu B; Yang N; Liu Y; Kong P; Han M; Li B
    Med Sci Monit; 2020 Aug; 26():e923876. PubMed ID: 32857753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.
    Chin SY; Wu PR; Shih YH; Yeh CM; Lee WR; Shen SC; Yeh KT; Jiang MC; Tseng JT
    Int J Clin Exp Pathol; 2015; 8(2):1393-401. PubMed ID: 25973023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential distributions of CSE1L/CAS and E-cadherin in the polarized and non-polarized epithelial glands of neoplastic colorectal epithelium.
    Uen WC; Tai CJ; Shen SC; Lee WR; Tsao TY; Deng WP; Chiou HY; Hsu CH; Hsieh CI; Liao CF; Jiang MC
    J Mol Histol; 2010 Oct; 41(4-5):259-66. PubMed ID: 20734115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.